Jamieson Wellness Inc. (OTCMKTS:JWLLF) Short Interest Down 76.6% in August

Jamieson Wellness Inc. (OTCMKTS:JWLLF) saw a significant decline in short interest during the month of August. As of August 14th, there was short interest totaling 94,875 shares, a decline of 76.6% from the July 30th total of 404,709 shares. Based on an average daily trading volume, of 6,636 shares, the days-to-cover ratio is currently 14.3 days.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Citigroup lowered shares of Jamieson Wellness to a “hold” rating in a research note on Friday, August 7th. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Jamieson Wellness in a report on Friday, May 8th. National Bank Financial reaffirmed an “outperform” rating on shares of Jamieson Wellness in a research note on Friday, June 26th. Finally, Royal Bank Of Canada downgraded Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a research report on Monday, August 10th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.

Jamieson Wellness Price Performance

Jamieson Wellness stock traded up $0.01 during midday trading on Friday, reaching $32.92. The stock had a trading volume of 300 shares, compared to its average volume of 5,080. Jamieson Wellness has a twelve month low of $23.88 and a twelve month high of $33.15. The stock’s 50-day simple moving average is $30.23 and its 200 day simple moving average is $27.13.

Jamieson Wellness Company Profile

Jamieson Wellness is a leading Canadian manufacturer and distributor of nutraceutical products, including vitamins, minerals, herbal remedies and dietary supplements. Founded in 1922, the company has grown to offer a diverse portfolio of formulations designed to support general health, immune function, digestion and other specialized wellness needs. Its flagship Jamieson brand is complemented by sub-brands such as bkind, reflecting a commitment to innovation and consumer choice across a range of tablet, capsule and gummy formats.

The company serves both domestic and international markets through a multi-channel approach that includes major mass and drug retailers, specialty stores and direct-to-consumer e-commerce platforms.